
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Find the Advantages of Deep rooted Getting the hang of: Extending Information and Self-awareness - 2
Favored Vehicle for Seniors: Make Your Determination - 3
Israel launches new wave of attacks against Hezbollah in Beirut - 4
As world leaders enter climate talks, people in poverty have the most at stake - 5
Bird flu poses risk of pandemic worse than COVID, France's Institut Pasteur says
See the famous winged horse Pegasus fly in the autumn night sky
April full moon 2026 dazzles as 'Pink Moon' lights up skies worldwide (photos)
James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
What will happen if Artemis 2 astronauts get hit by a solar storm during NASA's ambitious moon mission?
23 Most Amusing Messages At any point Sent Among Kids and Their Folks
10 Asian Countries Perfect for Solo Female Travelers
Beating Wellbeing Difficulties: Individual Victories in Health
James Webb Space Telescope spies mysterious high-energy radiation in star nursery
Jesse Jackson hospitalized, under observation for a neurodegenerative condition













